Gliablastoma multiform the cancer tumour in the article. I cannot see it linked to this company from the article.
Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-28
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable